These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25192052)

  • 1. Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.
    Ohta T; Kim YH; Oh JE; Satomi K; Nonoguchi N; Keyvani K; Pierscianek D; Sure U; Mittelbronn M; Paulus W; Vital A; Yokoo H; McDonald K; Kleihues P; Nazaret N; Barbet F; Lachuer J; Ohgaki H
    J Neuropathol Exp Neurol; 2014 Oct; 73(10):908-15. PubMed ID: 25192052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
    Okamoto Y; Di Patre PL; Burkhard C; Horstmann S; Jourde B; Fahey M; Schüler D; Probst-Hensch NM; Yasargil MG; Yonekawa Y; Lütolf UM; Kleihues P; Ohgaki H
    Acta Neuropathol; 2004 Jul; 108(1):49-56. PubMed ID: 15118874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H; Kleihues P
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.
    Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Pierscianek D; Kim YH; Mariani L; Vital A; Ohgaki H
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):702-7. PubMed ID: 22805772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
    Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
    J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
    Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
    Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H
    Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas.
    Reis RM; Hara A; Kleihues P; Ohgaki H
    Acta Neuropathol; 2001 Nov; 102(5):422-5. PubMed ID: 11699553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.
    Thon N; Eigenbrod S; Kreth S; Lutz J; Tonn JC; Kretzschmar H; Peraud A; Kreth FW
    Cancer; 2012 Jan; 118(2):452-60. PubMed ID: 21717448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlation in gemistocytic astrocytomas.
    Kösel S; Scheithauer BW; Graeber MB
    Neurosurgery; 2001 Jan; 48(1):187-93; discussion 193-4. PubMed ID: 11152345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia in gemistocytic astrocytomas.
    Geranmayeh F; Scheithauer BW; Spitzer C; Meyer FB; Svensson-Engwall AC; Graeber MB
    Neurosurgery; 2007 Jan; 60(1):159-66; discussion 166. PubMed ID: 17228265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGFRA gain in low-grade diffuse gliomas.
    Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Nonoguchi N; Pierscianek D; Kim YH; Mariani L; Vital A; Perry A; Ohgaki H
    J Neuropathol Exp Neurol; 2013 Jan; 72(1):61-6. PubMed ID: 23242283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.
    Yang P; Kollmeyer TM; Buckner K; Bamlet W; Ballman KV; Jenkins RB
    Cancer; 2005 Jun; 103(11):2363-72. PubMed ID: 15834925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemistocytic astrocytomas: a reappraisal.
    Krouwer HG; Davis RL; Silver P; Prados M
    J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.